• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for the diagnosis and management of adult myelodysplastic syndromes.

作者信息

Killick Sally B, Carter Chris, Culligan Dominic, Dalley Christopher, Das-Gupta Emma, Drummond Mark, Enright Helen, Jones Gail L, Kell Jonathan, Mills Juliet, Mufti Ghulam, Parker Jane, Raj Kavita, Sternberg Alexander, Vyas Paresh, Bowen David

机构信息

The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK.

出版信息

Br J Haematol. 2014 Feb;164(4):503-25. doi: 10.1111/bjh.12694. Epub 2013 Dec 23.

DOI:10.1111/bjh.12694
PMID:24372298
Abstract
摘要

相似文献

1
Guidelines for the diagnosis and management of adult myelodysplastic syndromes.成人骨髓增生异常综合征的诊断与管理指南
Br J Haematol. 2014 Feb;164(4):503-25. doi: 10.1111/bjh.12694. Epub 2013 Dec 23.
2
Myelodysplastic syndromes: state of the art pathology, diagnosis and management.骨髓增生异常综合征：最新的病理学、诊断与管理
Best Pract Res Clin Haematol. 2013 Dec;26(4):307-8. doi: 10.1016/j.beha.2014.01.002. Epub 2014 Jan 20.
3
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.骨髓增生异常综合征：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii57-69. doi: 10.1093/annonc/mdu180. Epub 2014 Jul 25.
4
[Expert consensus on diagnosis and treatment of myelodysplastic syndrome].[骨髓增生异常综合征诊断与治疗专家共识]
Zhonghua Xue Ye Xue Za Zhi. 2012 Apr;33(4):347-52.
5
JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-6 myelodysplastic syndromes (MDS).《日本血液学会（JSH）2018年血液系统恶性肿瘤实用指南：I. 白血病 - 6. 骨髓增生异常综合征（MDS）》
Int J Hematol. 2020 Apr;111(4):481-493. doi: 10.1007/s12185-020-02838-5. Epub 2020 Feb 14.
6
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.骨髓增生异常综合征：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Feb;32(2):142-156. doi: 10.1016/j.annonc.2020.11.002. Epub 2020 Nov 19.
7
[Diagnosis and treatment for myelodysplastic syndrome (MDS)].骨髓增生异常综合征（MDS）的诊断与治疗
Nihon Ronen Igakkai Zasshi. 2006 Jul;43(4):431-2. doi: 10.3143/geriatrics.43.431.
8
2021 BSH guidelines for the management of adult myelodysplastic syndromes: a practical approach to a challenging disease.
Br J Haematol. 2021 Jul;194(2):235-237. doi: 10.1111/bjh.17640. Epub 2021 Jun 28.
9
[Myelodysplastic syndromes. Diagnosis and care in patients over 70 years of age].[骨髓增生异常综合征。70岁以上患者的诊断与护理]
Presse Med. 1999 Oct 23;28(32):1771-8.
10
Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop.骨髓增生异常综合征 (MDS) 患者的诊断和预后评估进展更新：专家研讨会的共识声明和报告。
Leuk Res. 2012 Mar;36(3):264-70. doi: 10.1016/j.leukres.2011.11.005. Epub 2011 Dec 3.

引用本文的文献

1
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma.硫代端粒酶对硫氧还蛋白1和端粒酶的双靶向作用促进骨髓增生异常综合征和淋巴瘤的细胞死亡。
Biol Direct. 2025 Jan 15;20(1):7. doi: 10.1186/s13062-025-00594-2.
2
WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients.WT1 基因突变影响 2 例伴中高危骨髓增生异常综合征患者的移植后复发。
Ann Hematol. 2024 Aug;103(8):2827-2836. doi: 10.1007/s00277-024-05870-1. Epub 2024 Jul 6.
3
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.
低危或中危-1 风险骨髓增生异常综合征患者使用红细胞生成刺激剂的长期疗效：多中心真实世界数据。
Turk J Haematol. 2023 May 29;40(2):92-100. doi: 10.4274/tjh.galenos.2023.2022.0437. Epub 2023 Feb 17.
4
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.阿法依泊汀和阿法达贝泊汀治疗低危或中危-1骨髓增生异常综合征患者的临床疗效：回顾性多中心真实世界研究
Indian J Hematol Blood Transfus. 2022 Apr;38(2):299-308. doi: 10.1007/s12288-021-01458-1. Epub 2021 Jun 26.
5
Combination of HDE and BIIB021 efficiently inhibits cell proliferation and induces apoptosis via downregulating hTERT in myelodysplastic syndromes.HDE与BIIB021联合使用可通过下调骨髓增生异常综合征中的hTERT有效抑制细胞增殖并诱导细胞凋亡。
Exp Ther Med. 2021 May;21(5):503. doi: 10.3892/etm.2021.9934. Epub 2021 Mar 17.
6
Outpatient transfusions for myelodysplastic syndromes.骨髓增生异常综合征的门诊输血治疗。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):167-174. doi: 10.1182/hematology.2020000103.
7
Guideline-based indicators for adult patients with myelodysplastic syndromes.成人骨髓增生异常综合征基于指南的指标
Blood Adv. 2020 Aug 25;4(16):4029-4044. doi: 10.1182/bloodadvances.2020002314.
8
The Pulmonary Complications of Paraneoplastic Autoimmune Vasculitis in a Patient With Myelodysplastic Syndrome.骨髓增生异常综合征患者副肿瘤性自身免疫性血管炎的肺部并发症
Cureus. 2020 Jul 19;12(7):e9282. doi: 10.7759/cureus.9282.
9
Outcome of allogeneic hematopoietic stem cell transplantation for hypoplastic myelodysplastic syndrome.同种异体造血干细胞移植治疗低增生性骨髓增生异常综合征的结果。
Int J Hematol. 2020 Dec;112(6):825-834. doi: 10.1007/s12185-020-02969-9. Epub 2020 Aug 16.
10
Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes.单核苷酸多态性阵列技术为骨髓增生异常综合征患者生成有价值的风险分层信息。
Front Oncol. 2020 Jul 7;10:962. doi: 10.3389/fonc.2020.00962. eCollection 2020.